Page 227 - Read Online

Galicia-Moreno et al. Hepatoma Res 2020;6:20 I http://dx.doi.org/10.20517/2394-5079.2019.36 Page 15 of 18

Copyright
© The Author(s) 2020.

REFERENCES
1. Piñero F, Poniachik J, Ridruejo E, Silva M. Hepatocellular carcinoma in Latin America: diagnosis and treatment challenges. World J
Gastroenterol 2018;24:4224-9.
2. Fassio E, Díaz S, Santa C, Reig ME, Martínez Artola Y, et al. Etiology of hepatocellular carcinoma in Latin America: a prospective,
multicenter, international study. Ann Hepatol 2010;9:63-9.
3. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mather C, et al. Cancer incidence and mortality worldwide: sources, methods and major
patterns in GLOBOCAN 2012. In J Cancer 2015;136:E359-86.
4. Mcglynn KA, Petrick JL, London WT. Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional
variability. Clin Liver Dis 2015;19:223-38.
5. Méndez-Sánchez N, Ridruejo E, Alves de Mattos A, Chávez-Tapia NC, Zapata R, et al. Latin American Association for the Study of
the Liver (LAASL) clinical practice guidelines: management of hepatocellular carcinoma. Ann Hepatol 2014;13:S4-40.
6. Piñero F, Pages J, Marciano S, Fernández N, Silva J, et al. Fatty liver disease, an emerging etiology of hepatocellular carcinoma in
Argentina. World J Hepatol 2018;10:41-50.
7. IARC/WHO. GLOBOCAN 2019: Estimated cancer incidence, mortality and prevalence worldwide in 2019. Cancer today data base,
Population Fact Sheets. Available from: https://gco.iarc.fr/today/fact-sheets-populations [Last accessed on 16 Apr 2020]
8. Piñeiro F, Costa P, Boteon YL, Duque SH, Marciano S, et al. A changing etiologic scenario in liver transplantation for hepatocellular
carcinoma in a multicenter cohort study from Latin America. Clin Res Hepatol Gastroenterol 2018;42:443-52.
9. World Health Organization. Hepatitis B and C in the spotlight, a public health response in the America. 2016. Available from: http://
iris.paho.org/xmlui/bitstream/handle/123456789/31449/9789275119297eng.pdf?sequence=5&isAllowed=y [Last accessed on 16 Apr
2020]
10. Blach S, Zeuzem S, Manns M, Altraif I, Duberg AS, et al. Global prevalence and genotype distribution of hepatitis C virus infection in
2015: a modelling study. Lancet Gastroenterol Hepatol 2017;2:161-76.
11. World Health Organization. Global Hepatitis Report, World Health Organization. 2017. Available from: http://www.who.int/hepatitis
[Last accessed on 16 Apr 2020]
12. Centers for Disease Control and Prevention. The ABCs of Hepatitis Fact Sheet. 2016. Available from: www.cdc.gov/hepatitis [Last
accessed on 16 Apr 2020]
13. Liu Z, Jiang Y, Yuan H, Fang Q, Cai N, et al. The trends in incidence of primary liver cancer caused by specific etiologies: results from
the Global Burden of Disease Study 2016 and implications for liver cancer prevention. J Hepatol 2019;70:674-83.
14. Zein NN. Clinical significance of hepatitis C virus genotypes. Clin Microbiol Rev 2000;13:223-35.
15. Kershenobich D, Razavi HA, Sánchez-Avila JF, Bessone F, Coelho HS, et al. Trends and projections of hepatitis C virus epidemiology
in Latin America. Liver Int 2011;31:18-29.
16. Maucort-Boulch D, de Martel C, Franceschi S, Plummer M. Fraction and incidence of liver cancer attributable to hepatitis B and C
viruses worldwide. Int J Cancer 2018;142:2471-7.
17. Motola-Kuba D, Zamora-Valdes D, Uribe M, Méndez-Sánchez N. Hepatocellular carcinoma. An overview. Ann Hepatol 2006;5:16-24.
18. González Huezo MS, Sánchez Ávila JF; Asociación Mexicana de Hepatología; Asociación Mexicana de Gastroenterología; Sociedad
Mexicana de Radiología e Imagen, et al. Mexican consensus on the diagnosis and management of hepatocellular carcinoma. Rev
Gastroenterol Mex 2014;79:250-62.
19. Méndez-Sánchez N, Aguilar-Ramírez JR, Reyes A, Dehesa M, Juárez A, et al. Etiology of liver cirrhosis in Mexico. Ann Hepatol
2004;3:30-3.
20. Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology
2004;127:S35-50.
21. Weissenbacher M, Rossi D, Radulich G, Sosa-Estáni S, Vila M, et al. High seroprevalence of bloodborne viruses among street-
recruited injection drug users from Buenos Aires, Argentina. Clin Infect Dis 2003;15:S348-52.
22. Guimarães T, Granato CF, Varella D, Ferraz ML, Castelo A, et al. High prevalence of hepatitis C infection in a Brazilian prisión:
identification of risk factors for infection. Braz J Infect Dis 2001;5:111-28.
23. 23. Pando MA, Bautista CT, Maulen S, Duranti R, Marone R, et al. Epidemiology of human immunodeficiency virus, viral hepatitis
(B and C), treponema pallidum, and human T-cell, and human T-cell lymphotropic I/II virus among men who have sex with men in
Buenos Aires Argentina. Sex Transm Dis 2006;33:307-13.
24. Singal AG, Manjunath H, Yopp AC, Beg MS, Marrero JA, et al. The effect of PNPLA3 on fibrosis progression and development of the
hepatocellular carcinoma a meta-analysis. Am J Gastroenterol 2014;109:325-24.
25. Saab S, Manne V, Nieto J, Schwimmer JB, Chalasani NP. Nonalcoholic fatty liver disease in Latinos. Clin Gastroenterol Hepatol
2016;14:5-12.
26. Nordenstedt H, White D, El-Serag HB. The changing pattern of epidemiology in hepatocellular carcinoma. Dig Liver Dis
2010;42:s206-14.
27. Jiwani SS, Carrillo Larco RM, Hernández-Vásquez A, Barrientos-Gutiérrez T, Basto-Abreu A, et al. The shift of obesity burden by
socioeconomic status between 1998 and 2017 in Latin America and the Caribbean: a cross-sectional series study. Lancet Glob Health
2019;7:e1644-54.
28. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975
to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. Lancet